menu
    • menu

    Company profile for Addex Therapeutics

    NEW Drugs in Dev: 4
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. Allosteric modulators are an emerging class of small molecule drugs which have the potential to be more specific and confer significant therapeutic advantages over conventional "orthosteric" small molecule or biological drugs.Addex's allosteric modulator drug...
    Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. Allosteric modulators are an emerging class of small molecule drugs which have the potential to be more specific and confer significant therapeutic advantages over conventional "orthosteric" small molecule or biological drugs.Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention - the Addex pipeline was generated from this pioneering allosteric modulator drug discovery platform.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Addex TherapeuticsSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    12, chemin des Aulx, Case postale 68, 1228 Plan-les-Ouates, Geneva
    Telephone
    Telephone
    +41 22 884 1555
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.addextherapeutics.com/en/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/addex-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Addex Publishes Preclinical Data On mGlu7 NAMS For Anxiety
    Addex Publishes Preclinical Data On mGlu7 NAMS For Anxiety

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3230712/0/en/Addex-Announces-Publication-of-Preclinical-Data-Supporting-Potential-of-mGlu7-Negative-Allosteric-Modulators-to-Transform-Anxiety-and-Fear-Related-Disorder-Treatment.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    Neurosterix Launches Phase 1 Study of NTX-253 in Schizophrenia
    Neurosterix Launches Phase 1 Study of NTX-253 in Schizophrenia

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214260/0/en/Addex-Spin-Out-Neurosterix-has-started-a-Phase-1-Clinical-Study-with-M4-PAM-NTX-253-for-Schizophrenia.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Addex Amends Market Agreement With H.C. Wainwright & Co.
    Addex Amends Market Agreement With H.C. Wainwright & Co.

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203606/0/en/Addex-Amends-its-at-the-Market-Offering-Agreement-With-H-C-Wainwright-Co.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    Addex Therapeutics Reports Q3 2025 Results and Corporate Update
    Addex Therapeutics Reports Q3 2025 Results and Corporate Update

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3199484/0/en/Addex-Therapeutics-Reports-2025-Third-Quarter-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    Addex Therapeutics Reports Q3 2025 Results and Hosts Call
    Addex Therapeutics Reports Q3 2025 Results and Hosts Call

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196636/0/en/Addex-Therapeutics-to-Report-2025-Third-Quarter-Financial-Results-And-Host-Conference-Call-on-December-4-2025.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Addex Increases Issued Share Capital To Create Treasury Shares
    Addex Increases Issued Share Capital To Create Treasury Shares

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176123/0/en/Addex-Increases-Issued-Share-Capital-to-Create-Treasury-Shares.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search